Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin.

Respiratory syncytial virus (RSV) causes serious illness (lower respiratory illness) in preterm infants. RSV antibody-enriched immunoglobulin (RSVIG) that was lyophilized (LYO) protected against RSV lower respiratory illness. The Food and Drug Administration now requires an additional viral inactiva...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Groothuis, J R, Simoes, E A, Lehr, M V, Kramer, A A, Hemming, V G, Rodriguez, W J, Arrobio, J, Welliver, R C, Siber, G R
Formato: Artigo
Lenguaje:Inglês
Publicado: 1995
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC162602/
https://ncbi.nlm.nih.gov/pubmed/7793870
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares